$2.08
-0.12-5.45%
At Close: -
$2.12
0.041.92%
After Hours: 4:23 PM EDT
15 minutes delayed
Prelude Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Prelude Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.46 | $-0.42 | -9.52 % |
Mar 2024 | 2024-05-07 | $-0.42 | $-0.48 | 12.5 % |
Dec 2023 | 2024-02-15 | $-0.45 | $-0.49 | 8.16 % |
Sep 2023 | 2023-11-01 | $-0.45 | $-0.58 | 22.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Prelude Therapeutics (PRLD) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.46, which missed the estimate of $-0.42.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.